UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 333-225962
| Titan Medical Inc. |
| (Exact name of registrant as specified in its charter) |
| 76 Berkeley Street, Toronto, Ontario, Canada, M5A 2W7 |
| (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) |
| Common Shares |
| (Title of each class of securities covered by this Form) |
| Not Applicable |
| (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) |
Please place an X in the box(es) to designate the appropriate rule provisions(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | ☐ |
| Rule 12g-4(a)(2) | ☐ |
| Rule 12h-3(b)(1)(i) | ☒ |
| Rule 12h-3(b)(1)(ii) | ☐ |
| Rule 15d-6 | ☐ |
| Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: 245
Pursuant to the requirements of the Securities Exchange Act of 1934 Titan Medical Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: April 19, 2023 | By: | /s/ Cary G. Vance | |
| Name: | Cary G. Vance | ||
| Title: | President and Chief Executive Officer | ||